Results 201 to 210 of about 16,440,357 (384)

CellPredX, a computational framework for cross-data type, cross-sample, and cross-protocol cell type annotation through domain adaptation and deep metric learning. [PDF]

PLoS Comput Biol
Liu Y, Xia Y, Yan H, Shen LC, Zhu Y, Qiang JP, Wei G.   +6 more
europepmc   +1 more source

Supplementary Data for Newman JRB, Long A, Speake C, Greenbaum CJ, Cerosaletti K, Rich SS, Onengut-Gumuscu S, McIntyre LM, Buckner JH, Concannon P, "Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes", submitted to Communications Biology

, 2023
Jeremy R. B. Newman, Alice Long, Cate Speake, Carla J. Greenbaum, Karen Cerosaletti, Stephen S. Rich, Suna Onengut-Gomuscu, Lauren M. McIntyre, Patrick Concannon   +8 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Structural biology of Type IV secretion system [PDF]

Acta Crystallographica Section A Foundations of Crystallography, 2005
L. Terradot, R. Bayliss, C. Oomen, G. Leonard, G. Waksman   +4 more
openaire   +1 more source

GlycoRNAdb: a database of glycoRNA sequences, structures, abundance, and glycan information across tissues and cell lines. [PDF]

Nucleic Acids Res
Zheng C, Ao Y, Zhang Z, Mei S, Hafeez A, Teng W, Li B, Qu L, Miao Z, Zheng L.   +9 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

ADAR1-Mediated RNA Editing Regulates Innate Immunity in Pulmonary Hypertension. [PDF]

Circ Res
Shen Y, Bisserier M.
europepmc   +1 more source

The role of various collagen types in tumor biology: a review [PDF]

Yuchuan Zhou, Zhonghui Jiang, Lu Cao, Jianquan Yang   +3 more
openalex   +1 more source

Analysis of Task Commitment Types of Science Learning in High School Students' Biology Classification [PDF]

, 2013
Wonjung Kim, Jung-Ho Byeon, Yong‐Ju Kwon   +2 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source